Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.

Cancer Manag Res · 2010 · PMC3004582 · PMID 21188093

Europe PMC DOI

hedged sentence

0.1170

closest p · 2.3× alpha

0.1170

boldest claim

The sentences

a nonsignificant trendP = 0.117not close (p > 0.1)

In contrast, in women with ≤6 months since discontinuation of adjuvant tamoxifen therapy, a nonsignificant trend was reported toward prolonged PFS (HR = 0.78; 95% CI 0.57 to 1.07; P = 0.117).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.